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Abstract
Objective: To evaluate the predictive value of glycosylated 
haemoglobin and cortisol on admission, in critical care 
patients. 
Design: Prospective, observational, single centre study.
Setting: 14 bedded Intensive care unit of a tertiary-level 
university hospital.
Patients: 124 consecutive emergency medical and surgical 
patients.
Methods: Data collected on admission included patient 
demographics, medical history, medication, diagnosis, type 
of nutrition, TISS28 score, serum blood glucose, Glycosylated 
haemoglobin (HbA1c), cortisol, mean arterial blood pressure, 
and the use of inotropes in the first 24hrs.
Daily baseline tests included complete blood count, urea and 
electrolytes, creatinine, twice weekly liver function tests.
The primary outcome measure was intensive care unit 
mortality. Secondary outcome measures were ITU stay, days 
of ventilation, peak urea, peak creatinine, lowest platelet 
count, peak bilirubin, lowest Pa/FiO2, and the number of 
transfusions.
Measurements and results: 124 patients (mean age 56.2 
years SD 23.2) were included. Regression analysis was used to 
identify any potential predictors of outcome: HbA1c levels on 
admission were not found to be significantly associated with 
mortality (p=0.51), or any other secondary endpoints listed 
above. However, subgroup analysis revealed a predictive role 
of HbA1c with regards to length of ITU stay (p= 0.01) and 
number of days of ventilation (p=0.007) in those patients with 
a history of diabetes. Glucose level on admission emerged as an 
independent marker of mortality (p=0.009).  
Conclusions: This study suggests that HbA1c may not be a 
predictor of outcome in the general ITU population but may be 
of predictive value in diabetic ITU patients. On the other hand, 
blood glucose levels on admission emerged as a predictor of 
mortality, whilst no association was found between HbA1c and 
cortisol levels on admission.
Introduction
Hyperglycaemia has been well established as a factor 
determining mortality and morbidity in the intensive care 
setting. Furthermore, it has been demonstrated that actively 
maintaining tight glycaemic control has a direct effect on 
morbidity and mortality.1,2 
The effect on outcome of the level of glycaemic control in 
the period of time prior to admission is unknown. Thus we set 
out to look at the glycosylated haemoglobin (HbA1c) level on 
admission, which reflects the average blood glucose levels in the 
preceding four weeks3, to determine whether there is an effect 
on morbidity and mortality.
Furthermore, studies have shown that basal cortisol level 
may be an independent predictor of outcome.4-11 Cortisol is also 
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a well known factor affecting glucose metabolism12 promoting 
gluconeogenesis and having an anti-insulin effect in peripheral 
tissues. It has also been proposed that glucose levels may have a 
suppressor effect on cortisol production.13 The study, proposes 
to investigate any possible association between the glycaemic 
status in the preceding four weeks, as reflected by admission 
HbA1c, and the cortisol levels on admission.
Materials and methods
Study population
All adults undergoing emergency admission to our intensive 
care unit over a three month period were included in the study. 
Exclusion criteria included all elective postoperative admissions, 
as it was felt that preoperative optimisation would have skewed 
HbA1c levels, and all patients on steroids. Ethical procedures 
and practices related to the observational study were duly 
enacted.
On admission, baseline patient data collected included 
demographics, past medical history, drug history, reason for 
admission, type of nutrition, serum blood glucose, HbA1c, 
complete blood bount (CBC): haemoglobin, white cell count 
and platelet count, urea and electrolytes (U+E), creatinine and 
cortisol. A simplified Therapeutic Intervention Scoring System 
(TISS-28 score)14 was calculated for the first twenty-four hours. 
Higher TISS-28 scores indicate a higher number of therapeutic 
interventions. Each intervention was assigned 1 to 4 points and 
the points were then summed to obtain the overall score. Daily 
baseline tests included a full blood count, electrolytes, urea and 
creatinine. Arterial blood gases were taken at least 4 times daily, 
frequency being dictated by clinical requirements. Twice weekly 
liver function tests were also performed.
Outcome measures
The primary outcome measure was intensive care unit 
mortality. Secondary outcome measures were generic - 
number of days in the intensive care unit, and system specific. 
The latter were namely respiratory: number of days of 
ventilatory support, lowest Pa/FiO2 (arterial partial pressure 
of oxygen/inspiratory fraction of oxygen); renal: peak urea, 
peak creatinine; haematological: lowest platelet count and 
transfusion requirements during the entire patient stay; and 
hepatic: peak bilirubin. The choice of outcome variables was 
largely influenced by previous studies.1-5
The potential predictors under study included: HbA1c, 
cortisol on admission, glucose on admission, history of diabetes, 
age, gender.  TISS28 score in the first twenty-four hours, MAP 
in the first twenty-four hours, and the use of inotropes in the 
first twenty-four hours served as indicators of disease severity 
in the patients under study.
Statistical analysis
Univariate and multivariate regression analyses were 
performed to identify significant associations between the 
described outcome measures and potential predictors. Binary 
logistic regression was used to identify predictors of mortality, 
whereas linear regression was used to detect significant 
associations with morbidity. The Fisher’s exact test was used 
in determining whether the use of inotropes in the first twenty 
four-hours reflected a worse outcome. For all statistical analysis, 
P <0.05 was considered significant. SPSS statistical package 




A total of 124 patients were enrolled in the study. Baseline 
characteristics are shown in Table 1. 29.8% had a history 
of diabetes and the mean HbA1c on admission was 6.63% 
(SD 1.83). Mean population blood glucose on admission was 
11.7mmol/L (SD 7.55). 
Mortality
 Mean outcome data for mortality and morbidity is shown in 
Table 2. 27.3% of patients enrolled in the study did not survive. 
No significant difference in mortality (p = 0.687) was observed 
between patients with a positive (29.7% mortality) and a negative 
(25.9% mortality) history of diabetes. Univariate analysis, using 
binary logistic regression, of the possible predictors of mortality 
identified glucose on admission and age. TISS-28 and use of 
inotropes in the first twenty-four hours were also significant, 
reflecting the increased severity of illness. All patients off 
inotropes in the first twenty-four hours survived. Multivariate 
analysis (Table 3) then maintained glucose on admission (OR 
1.07) and TISS-28 (OR 1.17) as having an association with 
mortality. HbA1c levels were not found to have an effect on 
mortality (p=0.138). When the subgroup with a history of 
diabetes was analysed separately, non-significance persisted at 
a borderline p value of 0.06, as shown in Table 4. Regression 
analysis did not reveal any association between cortisol levels 
and mortality in neither the entire study group (table 3), nor in 
the diabetic subgroup (p=0.647, binary logistic regression). 
Morbidity
Multivariate analysis (Table 3) was carried out to identify 
any associations between the factors under study listed above, 
and the secondary outcome measures:
Length of ITU stay was associated with a history of diabetes 
and the use of inotropes in the first twenty-four hours. Patients 
without a history of diabetes spent an average 3.13 days more 
than their diabetic counterparts. Patients requiring inotropes 
in the first twenty-four hours (70 out of 124 patients) spent an 
average 4 days more on the unit. As shown in table 4, HbA1c 
was significantly associated with length of stay in those patients 
having a history of diabetes (p=0.02), such that for each unit 
increase in HbA1c levels there was an increase in stay by 1.26 
days.
The number of days a patient was being ventilated was 
associated with higher TISS-28 scores in the first twenty-four 
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hours, such that for each unit increase in TISS-28 score, the 
patient spent 0.28 days more on the ventilator. Also, patients 
requiring inotropes in the first twenty-four hours required 
3.38 days more of ventilation. Higher HbA1c levels were also 
associated with prolonged ventilation (p=0.03) in the subgroup 
having a history of diabetes, such that for each unit increase 
in HbA1c the patient spent an additional 1.36 days being 
ventilated.
Both peak serum creatinine and urea levels registered 
throughout the patients’ stay were significantly associated with 
the use of inotropes in the first twenty four-hours. Patients on 
inotropes had an average peak creatinine which was 95.7µmol/l 
higher than those not on inotropes. Similarly, peak urea 
levels were on average 8.7mmol/l higher in patients requiring 
inotropes in the first twenty-four hours.
Furthermore it was observed that for each unit increase in 
the TISS-28 score, there was a reduction in the lowest platelet 
count by 3.2x109/L.
Peak bilirubin levels were negatively associated with age; 
2.96mmol/L less for each yearly increase in age.
Lowest Pa/FiO2 ratios were significantly associated with 
TISS-28 score and the use of inotropes in the first twenty-four 
hours; those off inotropes had a ratio which was on average 
76.04 higher.
Transfusion requirements were only significantly associated 
with TISS-28 score performed in the first twenty-four hours. 
An additional transfusion of 0.1 units of packed cells was 
administered for each unit increase in TISS-28 score.
Furthermore, no significant correlation between HbA1c 
and a specific cortisol response on admission (n=51, p=0.06, 
CI=11.826 to 578.33) was found, nor was there any significant 
association between cortisol levels on admission and blood 
glucose on admission (n=51, p=0.238, CI=4.885x10-4 to 
1.918x10-3).
Discussion
The main aim of the study was to determine whether there 
is any predictive value to HbA1c levels in patients on admission 
to the intensive care unit. From the statistical analysis presented 
above, it would seem that there is no such association when 
the study population is taken as a whole. However, when the 
subgroup with a history of diabetes was analysed, an association 
between HbA1c and the number of days of ventilation and ITU 
stay emerged. A weak non-significant association with mortality 
was also identified (p=0.06). This could be partially explained 
by the fact that the HbA1c values in the whole population were 
within a low and narrow range (with a mean of 6.63% (SD 
1.47)). Conversely, it appears that HbA1c levels not within 
the normal range (i.e. 4.7% -6.4%), as in those patients with a 
history of diabetes (HbA1c mean 7.9%, SD 1.7) are of potential 
prognostic value.
However, the main weakness of the study is the relatively 
small cohort. As a result, this limitation is further accentuated 
when the sample is split into subgroups such that diabetic 
subgroup involves too small a population (n=37) for definitive 
conclusions to be drawn. 
The secondary aim of the study was to look at both the 
potential predictive role of cortisol on admission, as well as to 
identify any link between HbA1c levels and the cortisol levels. 
Table 1: Baseline characteristics
Characteristic No of patients (n=124)
Age/yrs (SD) 56.2 (23.2)
Male Sex – no. (%) 76.0 (61.3%)
History of Diabetes 37.0 (29.8%)
History of ischaemic heart disease 29.0 (23.4%)
History of chronic obstructive 
airways disease 11.0 (8.9%)
History  of chronic renal failure 7.0 (5.6%)
 Mean (SD)
HbA1c% 6.63 (1.83)
Glucose OA/mmol/L 11.70 (7.55)
Cortisol OA/mmol/L 1520.89 (1578.41)
Therapeutic intervention 
scoring system-28 in 1st 24hrs 41.10 (23.1)
Reason for admission to intensive care    n (%)
Abdominal Surgery 20  (16.6%)
Neurological 20  (16.6%)
Pneumonia 13  (10.8%)
Cardiopulmonary resuscitation 12  (10%)
Pulmonary oedema 10  (8.3%)
Trauma  10  (8.3%)
Sepsis 8  (6.6)
Drug overdose 6  (5%)
Haematemesis 4  (3.3%)
Cardiogenic shock 3  (2.5%)
Others 14  (14.4%)
Table 2: Patient outcome measures
Variable Mean SD Min-Max
Mortality (total n) (33)  
ITU stay /days 6.73 7.96 0-54
Ventilation days 4.90 7.47 0-51
Peak Urea/mmol/l 14.86 11.72 2-65
Peak Creatinine /mmol/l 187.12 220.42 30-1371
Platelets lowest/109/L 165.16 80.85 8-448
Peak bilirubin/mmol/l 48.67 160.03 4-1157
Lowest PaO2/FiO2 177.55 109.49 12-556
Transfusions per patient 0.60 2.10 0-15
PaO2: Arterial partial pressure of oxygen
FiO2: Inspiratory fraction of oxygen
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Table 3: Outcome p values. N=124
       Lowest  
       Mean 
       Arterial  
       Pressure TISS28 Inotropes
    Cortisol Glucose H/O in 1st in 1st in 1st
 Age Sex HbA1c OA OA Diabetes 24Hrs 24Hrs 24Hrs
Mortality1 0.052 0.93 0.138 0.53 (0.009) 0.61 0.078 (0.003) <0.0012
ITU stay 0.42 0.73 0.71 0.28 0.25 (0.046) 0.31 0.022 (0.005)
Ventilation days 0.129 0.73 0.497 0.428 0.109 0.100 0.15 (0.022) (0.001)
Peak Urea 0.16 (0.017) 0.17 0.48 0.31 (0.037) 0.056 0.024 (<0.001)
Peak Creatinine 0.59 (0.008) 0.247 0.97 0.75 0.235 0.84 0.38 (0.02)
Lowest Platelets 0.29 0.71 0.06 0.89 0.39 0.28 0.16 (0.022) 0.732
Peak Bilirubin (0.014) 0.33 0.331 0.82 0.40 0.565 0.61 0.32 0.513
Lowest Pa/FiO2 0.48 0.49 0.227 0.59 0.101 0.385 0.005 (<0.001) (<0.001)
Transfusions 0.49 0.118 0.252 0.855 0.831 0.826 0.106 (0.002) 0.577
Statistical test: Linear regression model unless stated otherwise
1 Binary Logistic Regression 
2 Fisher’s Exact Test
NB: Variables having statistical significance shown in bold. Variables significant after multivariate analysis shown in brackets
PaO2: Arterial partial pressure of oxygen
FiO2: Inspiratory fraction of oxygen
The association between cortisol on admission and outcome 
is quite contentious and mixed results have been reported in 
the literature.4,10,11 However, most studies have found cortisol 
levels on admission to be higher in non-survivors.5-9 Small 
sample size prevented subset analysis according to background 
pathology, but no association was found between cortisol levels 
on admission and outcome in the total population. Furthermore, 
we wanted to see if cortisol levels had an effect on blood 
glucose. Firstly, it seems that glycaemic control in the weeks 
preceding admission, as reflected by the HbA1c levels, were 
independent of the cortisol levels on admission. This could be 
partly explained by the temporal factors involved, since HbA1c 
provided a snapshot of glycaemic status over the preceding four 
weeks, whereas cortisol on admission and its effects on glucose 
metabolism are only reflected at the time of sampling and there 
was no way of knowing the cortisol levels prior to that. Secondly, 
there seemed to be no association between the cortisol levels 
on admission and the immediate glucose levels on admission, 
which would suggest that other factors in the stress response 
may be responsible for the hyperglycaemia (mean glucose on 
admission 11.7mmol/l, SD 7.55).
Hyperglycaemia, both in the intensive care setting and in 
in-hospital care, has been known to be associated with a worse 
outcome in both diabetic and non-diabetic patients.15-18 Our study 
suggests that the glucose level on admission is an independent 
marker of mortality in the population under study (p=0.009). 
The glycaemic status on admission did not seem to have an 
effect on morbidity in the total population (Table 3). However, 
when the subgroup having a history of diabetes was analysed 
separately, the trend seen above with HbA1c, was also reflected 
with the glucose level on admission. Thus, an association 
between glucose on admission and length of stay (p=0.01) and 
also the number of days of ventilation (p=0.007) is suggested. 
This is in keeping with previous studies which have shown that 
pulmonary oxygenation is impaired in diabetic patients, most 
likely due to pulmonary microangiopathy and nonenzymatic 
glycosylation-induced alteration of lung connective tissue.19,20 
Newer studies also show that glucose variability during the ITU 
stay is also a prognostic factor.21 Diabetic patients are usually 
started early on insulin infusions, and this could contribute to 
artificial swings in blood glucose.22
The interesting finding that a history of diabetes was actually 
associated with a reduction of ITU stay (average 3.13 days less) 
was difficult to explain. The reduction in ITU stay persisted 
even after the patients admitted with diabetic ketoacidosis 
were excluded. Indeed, the mortality rate was slightly higher 
in the diabetic group at 29.7% as compared to 25.9% in the 
non-diabetic group, and could account for the shorter stay, but 
no significant differences in mortality between the two groups 
was registered (p= 0.61). 
The use of resources, as gauged by the TISS-28 score, 
revealed some interesting findings. Indeed, the TISS-28 
performed in the first twenty-four hours of admission emerged 
as a marker of illness severity, with significant associations with 
both mortality (p=0.003) and morbidity (Table 3). Indeed, 
as expected, patients requiring considerable resources on 
admission, were sicker, developed complications, required 
lengthier care, and were less likely to survive.
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Table 4: Outcome measures in patients with 
a history of diabetes
 HbA1c Glucose 
  on admission
Mortality1 0.06 0.060
ITU stay 0.02 0.010
Ventilation days 0.03 0.007
Peak Urea 0.85 0.650
Peak Creatinine 0.79 0.300
Lowest Platelets 0.66 0.510
Peak Bilirubin 0.56 0.220
Lowest Pa/FiO2 0.30 0.190
Transfusions 0.14 0.440
Statistical test: Linear regression model unless stated 
otherwise
1 Binary Logistic Regression 
PaO2: Arterial partial pressure of oxygen
FiO2: Inspiratory fraction of oxygen
Also, patients requiring the use of inotropes in their first 
twenty-four hours of admission had a worse prognosis. Use 
of inotropes in the first twenty-four hours was associated with 
higher mortality (p<0.001) and worse respiratory and renal 
endpoints (Table 3). This can be partially explained by the notion 
that the use of inotropes improves immediate haemodynamics, 
but does not provide a stable clinical improvement and 
outcome.23 On the other hand, as with TISS-28 scores, the use 
of inotropes in the first twenty four-hours hours is more likely 
to reflect an increased disease severity and as expected24 such 
patients have worse morbidity and mortality.
Conclusions
Within the context of a limited sample size, this study 
suggests that HbA1c is not a predictor of outcome in the general 
ITU population, but may be of predictive value in diabetic ITU 
patients. Conversely, blood glucose levels on admission emerged 
as an independent predictor of mortality whilst no association 
was found between HbA1c and cortisol levels on admission.
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